Yenddy Carrero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yenddy Carrero has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
- Jesús Mosquera
Instituto de Investigaciones Clínicas “Dr. Américo Negrette”, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela
11 shared publications - Adriana Pedreañez
Catedra de Inmunologia, Escuela de Bioanalisis, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela
9 shared publications - Juan Pablo Hernandez-Fonseca
Instituto de Investigaciones Clínicas “Dr. Américo Negrette”, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela
6 shared publications - Lizette Elena Leiva Suero
Carrera de Medicina, Facultad de Ciencias de la Salud, Universidad Técnica de Ambato
5 shared publications - Mike Contreras
Universidad Federal de Goiás. Campus Colemar Natal e Silva. Instituto de Patologia Tropical e Saúde Publica. Área de imunologia. Goiânia-Goiás. Brasil
5 shared publications - Renata Vargas
Instituto de Investigaciones Clínicas “Dr. Américo Negrette”, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela
5 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1922814
Role of hypoxia-inducible factor – 1 alpha on the progression of cervical intraepithelial neoplasia and cervical cancer: a narrative review
Cervical cancer represents a global public health problem, hence the importance of optimizing therapeutic options and expanding knowledge of prognostic markers. Clinical and experimental evidence shows that hypoxia-inducible factor (HIF) is a key inducer of aggressive phenotypes in cervical cancer: promoting angiogenesis, invasion, epithelial-mesenchymal transition (EMT), modulation of the immune microenvironment, and contributing to resistance to radiotherapy/chemotherapy in a possible synergistic effect with the human papilloma virus oncogenes. Hypoxic microenvironments that modulate the early activation of HIF pathways may be present in pre-invasive lesions and favor the acquisition of invasive phenotypes that precede invasion. This review highlights the mechanisms of HIF-1α in the progression of cervical intraepithelial neoplasia and cervical cancer. In this regard, HIF-1α is involved in the expression of genes related to angiogenesis, apoptosis and progression such as GLUT1, uPAR, BIRC5, EPO, EpoR, LIMD1, VHL, MET and pro-angiogenic genes (VEGF, PGF, PDGF-β, PAI-1, MMP-2, MMP-9, ANG-1, ANG-2, using pathways such as YAP/TA2. However, the balance between antitumor factors (miR-143) and protumor factors can define the progression of this neoplasia. In the future, the characterization of hypoxia signatures and the evaluation of HIF-1α pathway inhibitors are promising tools for optimizing outcomes in the treatment of cervical cancer, integrated with modern, high-precision radiation therapy techniques and predictive models based on imaging and artificial intelligence, which represent a key pillar of personalized oncology in cervical cancer, with the potential to improve tumor control and reduce toxicity; however, specific clinical trials are still needed to validate their impact on survival and safety.
- 10 September 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1922814
Open AccessRole of hypoxia-inducible factor – 1 alpha on the progression of cervical intraepithelial neoplasia and cervical cancer: a narrative review
Cervical cancer represents a global public health problem, hence the importance of optimizing therapeutic options and expanding knowledge of prognostic markers. Clinical and experimental evidence shows that hypoxia-inducible factor (HIF) is a key inducer of aggressive phenotypes in cervical cancer: promoting angiogenesis, invasion, epithelial-mesenchymal transition (EMT), modulation of the immune microenvironment, and contributing to resistance to radiotherapy/chemotherapy in a possible synergistic effect with the human papilloma virus oncogenes. Hypoxic microenvironments that modulate the early activation of HIF pathways may be present in pre-invasive lesions and favor the acquisition of invasive phenotypes that precede invasion. This review highlights the mechanisms of HIF-1α in the progression of cervical intraepithelial neoplasia and cervical cancer. In this regard, HIF-1α is involved in the expression of genes related to angiogenesis, apoptosis and progression such as GLUT1, uPAR, BIRC5, EPO, EpoR, LIMD1, VHL, MET and pro-angiogenic genes (VEGF, PGF, PDGF-β, PAI-1, MMP-2, MMP-9, ANG-1, ANG-2, using pathways such as YAP/TA2. However, the balance between antitumor factors (miR-143) and protumor factors can define the progression of this neoplasia. In the future, the characterization of hypoxia signatures and the evaluation of HIF-1α pathway inhibitors are promising tools for optimizing outcomes in the treatment of cervical cancer, integrated with modern, high-precision radiation therapy techniques and predictive models based on imaging and artificial intelligence, which represent a key pillar of personalized oncology in cervical cancer, with the potential to improve tumor control and reduce toxicity; however, specific clinical trials are still needed to validate their impact on survival and safety.
- Open Access
- 20 August 2026
- Published by Frontiers Media SA in Frontiers in Tropical Diseases
- Vol. 7, 1897086
Reemergence of arboviruses in the Andean-Amazonian corridor: eco-epidemiological dynamics and surveillance in Colombia, Ecuador, and Venezuela
Re-emerging infectious diseases pose a growing threat to global public health, especially in tropical regions where environmental changes, rapid urbanization, declining vaccination coverage, and human mobility facilitate the transmission of various pathogens. Latin America is currently facing an unprecedented epidemiological crisis, with infectious diseases spreading amid conditions of inequality and fragmented health systems. The Andean-Amazonian corridor represents an epidemiological hotspot for various vector-borne diseases. The objective of this article was to analyze the epidemiological trends of re-emerging diseases in these countries from 2023 to 2026, identifying ecological, social, and health factors linked to their re-emergence. The results reveal a sustained increase in arboviruses such as dengue, chikungunya, and yellow fever, as well as the persistence of malaria in Amazonian areas. In Ecuador, 37,840 cases of dengue were reported in 2025, with 65 deaths, while in Colombia, an outbreak of yellow fever was recorded with 132 confirmed human cases from 2024 to 2025. The situation regarding yellow fever in Venezuela during 2025 and 2026 shows signs of reemergence within the regional context of South America, associated primarily with the circulation of the virus in sylvatic cycles and the risk of spread to neighboring areas. The findings indicate that the interaction between climate change, deforestation, migration, and evident weaknesses in epidemiological surveillance, vector control, limited access to health services, infodemic, poor health education, and vaccine hesitancy contribute to the reemergence. In conclusion, it is necessary to implement a One Health approach in Latin America, which is justified not by the number of reported cases, but by the magnitude of what remains undetected and unreported, as well as genomic surveillance to identify variants, trace transmissions, monitor drug resistance, and anticipate outbreaks, thereby transforming our understanding of complex, emerging, and often neglected diseases.
- 20 August 2026
- Published by Frontiers Media SA in Frontiers in Tropical Diseases
- Vol. 7, 1897086
Open AccessReemergence of arboviruses in the Andean-Amazonian corridor: eco-epidemiological dynamics and surveillance in Colombia, Ecuador, and Venezuela
Re-emerging infectious diseases pose a growing threat to global public health, especially in tropical regions where environmental changes, rapid urbanization, declining vaccination coverage, and human mobility facilitate the transmission of various pathogens. Latin America is currently facing an unprecedented epidemiological crisis, with infectious diseases spreading amid conditions of inequality and fragmented health systems. The Andean-Amazonian corridor represents an epidemiological hotspot for various vector-borne diseases. The objective of this article was to analyze the epidemiological trends of re-emerging diseases in these countries from 2023 to 2026, identifying ecological, social, and health factors linked to their re-emergence. The results reveal a sustained increase in arboviruses such as dengue, chikungunya, and yellow fever, as well as the persistence of malaria in Amazonian areas. In Ecuador, 37,840 cases of dengue were reported in 2025, with 65 deaths, while in Colombia, an outbreak of yellow fever was recorded with 132 confirmed human cases from 2024 to 2025. The situation regarding yellow fever in Venezuela during 2025 and 2026 shows signs of reemergence within the regional context of South America, associated primarily with the circulation of the virus in sylvatic cycles and the risk of spread to neighboring areas. The findings indicate that the interaction between climate change, deforestation, migration, and evident weaknesses in epidemiological surveillance, vector control, limited access to health services, infodemic, poor health education, and vaccine hesitancy contribute to the reemergence. In conclusion, it is necessary to implement a One Health approach in Latin America, which is justified not by the number of reported cases, but by the magnitude of what remains undetected and unreported, as well as genomic surveillance to identify variants, trace transmissions, monitor drug resistance, and anticipate outbreaks, thereby transforming our understanding of complex, emerging, and often neglected diseases.
- Top Cited PapersOpen Access
- 4 July 2026
- Published by Elsevier in Travel Medicine and Infectious Disease
- p. 103009
Reducing Communicable-Disease Risk After Earthquakes: Vaccination and Prevention Lessons for Venezuela’s Doublet
- 4 July 2026
- Published by Elsevier in Travel Medicine and Infectious Disease
- p. 103009
Top Cited PapersOpen AccessReducing Communicable-Disease Risk After Earthquakes: Vaccination and Prevention Lessons for Venezuela’s Doublet
- Open Access
- 28 May 2026
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 73, 102995
The 2026 FIFA World Cup: Communicable disease risks and advice for visitors to Canada, the United States, and Mexico
- 28 May 2026
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 73, 102995
Open AccessThe 2026 FIFA World Cup: Communicable disease risks and advice for visitors to Canada, the United States, and Mexico
- 14 November 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 120 (4) , 291-301
C-reactive protein as an effector molecule in dengue pathogenesis: a review
Dengue is an infectious disease caused by the bite of a mosquito (Aedes aegypti) infected with the dengue virus and represents the world’s most common arboviral infection. Dengue is most common in tropical and subtropical areas and it has become a threat to human life. This disease induces high immune system activation resulting in an inflammatory process. C-reactive protein (CRP) as a marker of inflammation in various diseases has been studied; however, there are few studies that analyse it as an effector molecule in inflammatory disease pathogenesis. This review summarizes the current published literature through 2025 (on PubMed, Embase and Web of Science) regarding the factors that affect the pathogenesis of dengue mediated by CRP. The role of CRP in dengue pathogenesis may be related to its effects on complement activation, alterations of the coagulation system, thrombocytopaenia, alteration of vascular permeability, induction of liver damage and its interaction with Fc receptors and dendritic cells. These data strongly suggest a role for CRP in dengue pathogenesis.
- 14 November 2025
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 120 (4) , 291-301
C-reactive protein as an effector molecule in dengue pathogenesis: a review
Dengue is an infectious disease caused by the bite of a mosquito (Aedes aegypti) infected with the dengue virus and represents the world’s most common arboviral infection. Dengue is most common in tropical and subtropical areas and it has become a threat to human life. This disease induces high immune system activation resulting in an inflammatory process. C-reactive protein (CRP) as a marker of inflammation in various diseases has been studied; however, there are few studies that analyse it as an effector molecule in inflammatory disease pathogenesis. This review summarizes the current published literature through 2025 (on PubMed, Embase and Web of Science) regarding the factors that affect the pathogenesis of dengue mediated by CRP. The role of CRP in dengue pathogenesis may be related to its effects on complement activation, alterations of the coagulation system, thrombocytopaenia, alteration of vascular permeability, induction of liver damage and its interaction with Fc receptors and dendritic cells. These data strongly suggest a role for CRP in dengue pathogenesis.
- 19 October 2025
- Published by Elsevier in Pathology - Research and Practice
- Vol. 276, 156274
Role of C-reactive protein in cervical intraepithelial neoplasia/cancer
- 19 October 2025
- Published by Elsevier in Pathology - Research and Practice
- Vol. 276, 156274
Role of C-reactive protein in cervical intraepithelial neoplasia/cancer
- 2 May 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 35 (3) , e70040
Role of Angiotensin II in Venezuelan Equine Encephalitis: Narrative Review
Venezuelan equine encephalitis virus (VEEV) is an alphavirus in the family Togaviridae, transmitted by a mosquito bite and is highly infectious in aerosol form. Inflammation plays a role of antiviral response as well as development of lethal encephalitis. Infection through a mosquito bite is biphasic, beginning with an inflammatory process and viral replication in different organs with subsequent infiltration to the central nervous system (CNS), inducing encephalitis. The direct route is through inhalation of aerosols containing the virus with direct brain infection through the olfactory nerve. Significant damage is due to exacerbated inflammation in the host. Angiotensin II (Ang II) is a molecule with high pro‐inflammatory capacity, which has been found to be upregulated in the brain of VEEV‐infected rats, suggesting its role in the pathogenesis of this disease. Limited information regarding the association of Ang II expression with VEEV brain infection has been reported. The aim of this review is to highlight published reports indicating a possible association between Ang II expression and VEEV‐induced encephalitis. Several studies reflect a possible expression and function of Ang II during VEEV infection. Factors such as the relationship of Ang II with proteins involved in viral replication and entry into the cell (furin, Rab5, Rab7), activation of protein kinase C (necessary for the phosphorylation of VEEV), presence of microRNAs related to viral biology, increased permeability of the blood‐brain barrier, and use of transcription pathways common to Ang II and VEEV, may conceivable an association of Ang II with the pathogenesis of VEEV encephalitis.
- 2 May 2025
- Published by Wiley in Reviews in Medical Virology
- Vol. 35 (3) , e70040
Role of Angiotensin II in Venezuelan Equine Encephalitis: Narrative Review
Venezuelan equine encephalitis virus (VEEV) is an alphavirus in the family Togaviridae, transmitted by a mosquito bite and is highly infectious in aerosol form. Inflammation plays a role of antiviral response as well as development of lethal encephalitis. Infection through a mosquito bite is biphasic, beginning with an inflammatory process and viral replication in different organs with subsequent infiltration to the central nervous system (CNS), inducing encephalitis. The direct route is through inhalation of aerosols containing the virus with direct brain infection through the olfactory nerve. Significant damage is due to exacerbated inflammation in the host. Angiotensin II (Ang II) is a molecule with high pro‐inflammatory capacity, which has been found to be upregulated in the brain of VEEV‐infected rats, suggesting its role in the pathogenesis of this disease. Limited information regarding the association of Ang II expression with VEEV brain infection has been reported. The aim of this review is to highlight published reports indicating a possible association between Ang II expression and VEEV‐induced encephalitis. Several studies reflect a possible expression and function of Ang II during VEEV infection. Factors such as the relationship of Ang II with proteins involved in viral replication and entry into the cell (furin, Rab5, Rab7), activation of protein kinase C (necessary for the phosphorylation of VEEV), presence of microRNAs related to viral biology, increased permeability of the blood‐brain barrier, and use of transcription pathways common to Ang II and VEEV, may conceivable an association of Ang II with the pathogenesis of VEEV encephalitis.
- 5 April 2025
- Published by Springer Nature in Diabetology International
- Vol. 16 (3) , 469-482
Mechanisms of angiotensin II to induce depression in diabetes
The expression of angiotensin II (Ang II) has been reported in diabetes associated with hypertension and inflammatory processes. It has also been reported a link between Ang II, depression and diabetes; however, underlying mechanisms of Ang II-induced depression in this disease remain unclear. This review focuses on the possible mechanisms of Ang II to induce depression in diabetes. Ang II can induce pro-inflammatory events that activate indoleamine 2,3-dioxygenase and kynurenine monooxygenase. These activated enzymes act by decreasing the production of serotonin and increasing the production of quinolinic acid which acts on the N-methyl-d-aspartate receptor and the amino-methyl propionic acid receptor inducing decreased brain-derived neurotrophic factor (BDNF) expression and depression. Ang II can also induce the production of galectin 3 which has a depressant effect. Neuroinflammation induced by Ang II during diabetes can alter brain cells, event associated with functional disorders and depression. Furthermore, Ang II is capable of inducing oxidative stress in diabetes linked to depressive behaviors. In conclusion, Ang II has the potential to induce depression during diabetes through different mechanisms that involve inflammatory processes, oxidative stress, the production of galectin 3, and decrease in serotonin and BDNF. These findings open the possibility of using anti-Ang II drugs for the treatment of depressive behavior in diabetes.
- 5 April 2025
- Published by Springer Nature in Diabetology International
- Vol. 16 (3) , 469-482
Mechanisms of angiotensin II to induce depression in diabetes
The expression of angiotensin II (Ang II) has been reported in diabetes associated with hypertension and inflammatory processes. It has also been reported a link between Ang II, depression and diabetes; however, underlying mechanisms of Ang II-induced depression in this disease remain unclear. This review focuses on the possible mechanisms of Ang II to induce depression in diabetes. Ang II can induce pro-inflammatory events that activate indoleamine 2,3-dioxygenase and kynurenine monooxygenase. These activated enzymes act by decreasing the production of serotonin and increasing the production of quinolinic acid which acts on the N-methyl-d-aspartate receptor and the amino-methyl propionic acid receptor inducing decreased brain-derived neurotrophic factor (BDNF) expression and depression. Ang II can also induce the production of galectin 3 which has a depressant effect. Neuroinflammation induced by Ang II during diabetes can alter brain cells, event associated with functional disorders and depression. Furthermore, Ang II is capable of inducing oxidative stress in diabetes linked to depressive behaviors. In conclusion, Ang II has the potential to induce depression during diabetes through different mechanisms that involve inflammatory processes, oxidative stress, the production of galectin 3, and decrease in serotonin and BDNF. These findings open the possibility of using anti-Ang II drugs for the treatment of depressive behavior in diabetes.
- Top Cited PapersOpen Access
- 18 March 2025
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 65, 102839
Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama
- 18 March 2025
- Published by Elsevier in Travel Medicine and Infectious Disease
- Vol. 65, 102839
Top Cited PapersOpen AccessInfectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama
- Open Access
Microencapsulation of Anthocyanins from Zea mays and Solanum tuberosum: Impacts on Antioxidant, Antimicrobial, and Cytotoxic Activities
Objectives: This study investigates the biological activities of microencapsulated anthocyanins extracted from two Andean ancestral edible plants, Solanum tuberosum, and Zea mays, with a focus on their potential applications in functional foods and therapeutics. The primary objective was to evaluate their antioxidant, antimicrobial, and cytotoxic properties alongside structural and functional analyses of the microencapsulation process. Methods: Anthocyanins were extracted and microencapsulated using maltodextrin as a carrier. Fourier-transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) were employed to analyze the stability and structure of the microencapsulated particles. The antioxidant, antimicrobial, and cytotoxic activities of the microencapsulated were assessed through established assays. Results:S. tuberosum exhibited superior antioxidant capacity and potent anticancer activity against HepG2 and THJ29T cell lines, while Z. mays demonstrated significant antimicrobial efficacy against multidrug-resistant bacterial strains and biofilm-forming pathogens. Fourier-transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) confirmed the stabilization of anthocyanins within a maltodextrin matrix, enhancing their bioavailability and application potential. Conclusions: These results highlight the versatility of microencapsulated anthocyanins as bioactive agents for industrial and therapeutic applications. Future studies should explore in vivo validation and synergistic formulations to optimize their efficacy and broaden their use in nutraceutical and pharmaceutical fields.
Open AccessMicroencapsulation of Anthocyanins from Zea mays and Solanum tuberosum: Impacts on Antioxidant, Antimicrobial, and Cytotoxic Activities
Objectives: This study investigates the biological activities of microencapsulated anthocyanins extracted from two Andean ancestral edible plants, Solanum tuberosum, and Zea mays, with a focus on their potential applications in functional foods and therapeutics. The primary objective was to evaluate their antioxidant, antimicrobial, and cytotoxic properties alongside structural and functional analyses of the microencapsulation process. Methods: Anthocyanins were extracted and microencapsulated using maltodextrin as a carrier. Fourier-transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) were employed to analyze the stability and structure of the microencapsulated particles. The antioxidant, antimicrobial, and cytotoxic activities of the microencapsulated were assessed through established assays. Results:S. tuberosum exhibited superior antioxidant capacity and potent anticancer activity against HepG2 and THJ29T cell lines, while Z. mays demonstrated significant antimicrobial efficacy against multidrug-resistant bacterial strains and biofilm-forming pathogens. Fourier-transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) confirmed the stabilization of anthocyanins within a maltodextrin matrix, enhancing their bioavailability and application potential. Conclusions: These results highlight the versatility of microencapsulated anthocyanins as bioactive agents for industrial and therapeutic applications. Future studies should explore in vivo validation and synergistic formulations to optimize their efficacy and broaden their use in nutraceutical and pharmaceutical fields.